The Ibn Sina Pharmaceutical Industry Limited announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was BDT 1,246.155 million compared to BDT 1,234.368 million a year ago. Operating income was BDT 151.368 million compared to BDT 147.453 million a year ago. Net income was BDT 109.870 million compared to BDT 107.138 million a year ago. Basic earnings per share was BDT 3.52 compared to BDT 3.43 a year ago. For the half year, sales was BDT 2,571.471 million compared to BDT 2,469.779 million a year ago. Operating income was BDT 261.548 million compared to BDT 240.447 million a year ago. Net income was BDT 186.276 million compared to BDT 169.106 million a year ago. Basic earnings per share was BDT 5.96 compared to BDT 5.41 a year ago.